UniProtKB - P15941 (MUC1_HUMAN)
Mucin-1
MUC1
Functioni
Miscellaneous
Caution
GO - Molecular functioni
- p53 binding Source: BHF-UCL
- RNA polymerase II cis-regulatory region sequence-specific DNA binding Source: BHF-UCL
- transcription coregulator activity Source: BHF-UCL
GO - Biological processi
- cytokine-mediated signaling pathway Source: Reactome
- DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest Source: BHF-UCL
- DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator Source: BHF-UCL
- negative regulation of cell adhesion mediated by integrin Source: CACAO
- negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator Source: BHF-UCL
- negative regulation of transcription by competitive promoter binding Source: BHF-UCL
- O-glycan processing Source: Reactome
- positive regulation of histone H4 acetylation Source: BHF-UCL
- positive regulation of transcription from RNA polymerase II promoter in response to stress Source: BHF-UCL
- regulation of transcription from RNA polymerase II promoter in response to stress Source: BHF-UCL
- stimulatory C-type lectin receptor signaling pathway Source: Reactome
Enzyme and pathway databases
PathwayCommonsi | P15941 |
Reactomei | R-HSA-5083625, Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) R-HSA-5083632, Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) R-HSA-5083636, Defective GALNT12 causes colorectal cancer 1 (CRCS1) R-HSA-5621480, Dectin-2 family R-HSA-6785807, Interleukin-4 and Interleukin-13 signaling R-HSA-913709, O-linked glycosylation of mucins R-HSA-977068, Termination of O-glycan biosynthesis |
SIGNORi | P15941 |
Protein family/group databases
MEROPSi | S71.001 |
Names & Taxonomyi
Protein namesi | Recommended name: Mucin-1Short name: MUC-1 Alternative name(s): Breast carcinoma-associated antigen DF3 Cancer antigen 15-3 Short name: CA 15-3 Carcinoma-associated mucin Episialin H23AG Krebs von den Lungen-6 Short name: KL-6 PEMT Peanut-reactive urinary mucin Short name: PUM Polymorphic epithelial mucin Short name: PEM Tumor-associated epithelial membrane antigen Short name: EMA Tumor-associated mucin CD_antigen: CD227 Cleaved into the following 2 chains: Alternative name(s): MUC1-CT |
Gene namesi | Name:MUC1 Synonyms:PUM |
Organismi | Homo sapiens (Human) |
Taxonomic identifieri | 9606 [NCBI] |
Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Proteomesi |
|
Organism-specific databases
EuPathDBi | HostDB:ENSG00000185499.16 |
HGNCi | HGNC:7508, MUC1 |
MIMi | 113720, gene 158340, gene |
neXtProti | NX_P15941 |
Subcellular locationi
Plasma membrane
- Apical cell membrane 8 Publications; Single-pass type I membrane protein 8 Publications
Note: Exclusively located in the apical domain of the plasma membrane of highly polarized epithelial cells. After endocytosis, internalized and recycled to the cell membrane. Located to microvilli and to the tips of long filopodial protusions.
Extracellular region or secreted
Extracellular region or secreted
Extracellular region or secreted
Nucleus
Plasma membrane
Other locations
Note: On EGF and PDGFRB stimulation, transported to the nucleus through interaction with CTNNB1, a process which is stimulated by phosphorylation. On HRG stimulation, colocalizes with JUP/gamma-catenin at the nucleus.
Extracellular region or secreted
- extracellular exosome Source: UniProtKB
- extracellular space Source: UniProtKB
Golgi apparatus
- Golgi lumen Source: Reactome
Nucleus
- nuclear chromatin Source: BHF-UCL
Plasma Membrane
- apical plasma membrane Source: GO_Central
- integral component of plasma membrane Source: ProtInc
- plasma membrane Source: HPA
Other locations
- vesicle Source: UniProtKB
Topology
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Topological domaini | 24 – 1158 | ExtracellularSequence analysisAdd BLAST | 1135 | |
Transmembranei | 1159 – 1181 | HelicalSequence analysisAdd BLAST | 23 | |
Topological domaini | 1182 – 1255 | CytoplasmicSequence analysisAdd BLAST | 74 |
Keywords - Cellular componenti
Cell membrane, Cytoplasm, Membrane, Nucleus, SecretedPathology & Biotechi
Involvement in diseasei
Medullary cystic kidney disease 1 (MCKD1)1 Publication
Mutagenesis
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Mutagenesisi | 1098 | S → A, D, E, F, G, H, I, K, L, M, N, P, Q, R, V, W or Y: Completely abrogates cleavage. 1 Publication | 1 | |
Mutagenesisi | 1098 | S → C or T: Almost complete cleavage. 1 Publication | 1 | |
Mutagenesisi | 1116 | D → A: Greatly reduced formation of isoform 5/isoform Y complex. 1 Publication | 1 | |
Mutagenesisi | 1116 | D → E: No effect on formation of isoform 5/isoform Y complex. 1 Publication | 1 | |
Mutagenesisi | 1184 | C → A: S-palmitoylation reduced by 50%. Complete loss of palmitoylation, no effect on endocytosis, recycling inhibited and AP1S1 binding reduced by 30%; when associated with C-1186. Accumulates in intracellular compartments; when associated with C-1186 and N-1203. 1 Publication | 1 | |
Mutagenesisi | 1186 | C → A: S-palmitoylation reduced by 50%. Complete loss of palmitoylation, no effect on endocytosis, recycling inhibited, and AP1S1 binding reduced by 30%; when associated with C-1184. Accumulates in intracellular compartments; when associated with C-1184 and N-1203. 1 Publication | 1 | |
Mutagenesisi | 1187 – 1189 | RRK → AAA: No nuclear targeting of HRG-stimulated MUC1 C-terminal nor JUP/gamma-catenin. No effect on interaction with JUP/gamma-catenin. 2 Publications | 3 | |
Mutagenesisi | 1187 – 1189 | RRK → QQQ: No effect on palmitoylation. 2 Publications | 3 | |
Mutagenesisi | 1191 | Y → F: No effect on EGFR-mediated phosphorylation. 2 Publications | 1 | |
Mutagenesisi | 1191 | Y → N: No effect on endocytosis. 2 Publications | 1 | |
Mutagenesisi | 1203 | Y → E: No effect on nuclear colocalization of MUC1CT and CTNNB1. No effect on in vitro PDFGR-induced cell invasiveness. 4 Publications | 1 | |
Mutagenesisi | 1203 | Y → F: No effect on EGFR-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-induced cell invasiveness. 4 Publications | 1 | |
Mutagenesisi | 1203 | Y → N: Reduced endocytosis by 30%. Greatly reduced binding to AP1S2 and GRB2. Binding AP1S1 reduced by 25%. Reduced endocytosis by 77%; when associated with N-1243. Accumulates in intracellular compartments; when associated with C-1184 and C-1186. 4 Publications | 1 | |
Mutagenesisi | 1209 | Y → F: Some reduction in EGFR-mediated phosphorylation. 1 Publication | 1 | |
Mutagenesisi | 1218 | Y → F: No effect on EGFR-mediated phosphorylation. No nuclear colocalization of MUC1CT and CTNNB1. 2 Publications | 1 | |
Mutagenesisi | 1223 | S → A: No change in PRKCD- nor GSK3B-mediated phosphorylation. 2 Publications | 1 | |
Mutagenesisi | 1224 | T → A: Loss of PRKCD-mediated phosphorylation. Decreased PRKCD binding. No increased binding to CTNNB1 in the presence of autophosphorylated PRKCD. Increases formation of E-cadherin/beta-catenin complex. 1 Publication | 1 | |
Mutagenesisi | 1227 | S → A: No change in PRKCD-mediated phosphorylation. Loss of GSK3B-mediated phosphorylation. CTNNB1. 2 Publications | 1 | |
Mutagenesisi | 1229 | Y → F: Greatly reduced EGFR- and Src-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-mediated phosphorylation. Decreased Src-binding. 4 Publications | 1 | |
Mutagenesisi | 1229 | Y → N: No effect on endocytosis. 4 Publications | 1 | |
Mutagenesisi | 1243 | Y → N: Reduces binding to AP1S2 by 33%. Greatly reduced binding to GRB2. Reduced endocytosis by 50%. Reduced endocytosis by 77%; when associated with N-1203. 1 Publication | 1 |
Keywords - Diseasei
Tumor suppressorOrganism-specific databases
DisGeNETi | 4582 |
GeneReviewsi | MUC1 |
MalaCardsi | MUC1 |
MIMi | 174000, phenotype |
OpenTargetsi | ENSG00000185499 |
Orphaneti | 88949, MUC1-related autosomal dominant tubulointerstitial kidney disease |
PharmGKBi | PA31309 |
Miscellaneous databases
Pharosi | P15941, Tbio |
Chemistry databases
ChEMBLi | CHEMBL3580494 |
DrugBanki | DB11090, Potassium nitrate DB06584, TG4010 |
Polymorphism and mutation databases
BioMutai | MUC1 |
DMDMi | 296439295 |
PTM / Processingi
Molecule processing
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Signal peptidei | 1 – 23 | 2 PublicationsAdd BLAST | 23 | |
ChainiPRO_0000019277 | 24 – 1255 | Mucin-1Add BLAST | 1232 | |
ChainiPRO_0000317446 | 24 – 1097 | Mucin-1 subunit alphaAdd BLAST | 1074 | |
ChainiPRO_0000317447 | 1098 – 1255 | Mucin-1 subunit betaAdd BLAST | 158 |
Amino acid modifications
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Glycosylationi | 131 | O-linked (GalNAc...) threonine2 Publications | 1 | |
Glycosylationi | 139 | O-linked (GalNAc...) threonine2 Publications | 1 | |
Glycosylationi | 140 | O-linked (GalNAc...) serineSequence analysis | 1 | |
Glycosylationi | 144 | O-linked (GalNAc...) threonineSequence analysis | 1 | |
Glycosylationi | 957 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
Glycosylationi | 975 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
Glycosylationi | 1029 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
Glycosylationi | 1055 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
Glycosylationi | 1133 | N-linked (GlcNAc...) asparagineSequence analysis | 1 | |
Lipidationi | 1184 | S-palmitoyl cysteine1 Publication | 1 | |
Lipidationi | 1186 | S-palmitoyl cysteine1 Publication | 1 | |
Modified residuei | 1203 | Phosphotyrosine; by PDGFR2 Publications | 1 | |
Modified residuei | 1212 | Phosphotyrosine1 Publication | 1 | |
Modified residuei | 1218 | Phosphotyrosine; by PDGFR1 Publication | 1 | |
Modified residuei | 1224 | Phosphothreonine; by PKC/PRKCD1 Publication | 1 | |
Modified residuei | 1227 | Phosphoserine; by GSK3-betaCombined sources1 Publication | 1 | |
Modified residuei | 1229 | Phosphotyrosine; by CSK, EGFR and SRC4 Publications | 1 | |
Modified residuei | 1243 | Phosphotyrosine1 Publication | 1 |
Post-translational modificationi
Sites
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Sitei | 1097 – 1098 | Cleavage; by autolysis | 2 |
Keywords - PTMi
Autocatalytic cleavage, Disulfide bond, Glycoprotein, Lipoprotein, Palmitate, PhosphoproteinProteomic databases
CPTACi | CPTAC-146 CPTAC-147 CPTAC-719 CPTAC-730 |
jPOSTi | P15941 |
MassIVEi | P15941 |
MaxQBi | P15941 |
PaxDbi | P15941 |
PeptideAtlasi | P15941 |
PRIDEi | P15941 |
ProteomicsDBi | 1779 53249 [P15941-1] 53250 [P15941-10] 53251 [P15941-2] 53252 [P15941-3] 53253 [P15941-4] 53254 [P15941-5] 53255 [P15941-6] 53256 [P15941-7] 53257 [P15941-8] 53258 [P15941-9] 58806 6245 69255 69256 767 |
PTM databases
GlyConnecti | 372, 9 O-Linked glycans 373, 8 O-Linked glycans 374, 8 O-Linked glycans 375, 10 O-Linked glycans 376, 10 O-Linked glycans 377, 7 O-Linked glycans 413, 5 N-Linked glycans (1 site), 14 O-Linked glycans |
GlyGeni | P15941, 13 sites, 5 O-linked glycans (4 sites) |
iPTMneti | P15941 |
PhosphoSitePlusi | P15941 |
SwissPalmi | P15941 |
UniCarbKBi | P15941 |
Expressioni
Tissue specificityi
Developmental stagei
Gene expression databases
Bgeei | ENSG00000185499, Expressed in body of stomach and 212 other tissues |
ExpressionAtlasi | P15941, baseline and differential |
Genevisiblei | P15941, HS |
Organism-specific databases
HPAi | ENSG00000185499, Tissue enhanced (gallbladder, kidney, lung) |
Interactioni
Subunit structurei
The alpha subunit forms a tight, non-covalent heterodimeric complex with the proteolytically-released beta-subunit. Interaction, via the tandem repeat region, with domain 1 of ICAM1 is implicated in cell migration and metastases. Isoform 1 binds directly the SH2 domain of GRB2, and forms a MUC1/GRB2/SOS1 complex involved in RAS signaling. The cytoplasmic tail (MUC1CT) interacts with several proteins such as SRC, CTNNB1 and ERBs. Interaction with the SH2 domain of CSK decreases interaction with GSK3B.
Interacts with CTNNB1/beta-catenin and JUP/gamma-catenin and promotes cell adhesion. Interaction with JUP/gamma-catenin is induced by heregulin. Binds PRKCD, ERBB2, ERBB3 and ERBB4. Heregulin (HRG) stimulates the interaction with ERBB2 and, to a much lesser extent, the interaction with ERBB3 and ERBB4.
Interacts with P53 in response to DNA damage.
Interacts with KLF4.
Interacts with estrogen receptor alpha/ESR1, through its DNA-binding domain, and stimulates its transcription activity. Binds ADAM17. Isoform ZD forms disulfide-linked oligomers.
21 PublicationsBinary interactionsi
P15941
Isoform Y-LSP [P15941-11]
Mucin-1 subunit beta (PRO_0000317447)
With | #Exp. | IntAct |
---|---|---|
CEBPB [P17676] | 8 | EBI-10053698,EBI-969696 |
GO - Molecular functioni
- p53 binding Source: BHF-UCL
Protein-protein interaction databases
BioGRIDi | 110669, 147 interactors |
DIPi | DIP-41890N |
IntActi | P15941, 121 interactors |
MINTi | P15941 |
STRINGi | 9606.ENSP00000484824 |
Miscellaneous databases
RNActi | P15941, protein |
Structurei
Secondary structure
3D structure databases
SMRi | P15941 |
ModBasei | Search... |
PDBe-KBi | Search... |
Miscellaneous databases
EvolutionaryTracei | P15941 |
Family & Domainsi
Domains and Repeats
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Repeati | 61 – 80 | 1; approximate1 PublicationAdd BLAST | 20 | |
Repeati | 81 – 100 | 2; approximate1 PublicationAdd BLAST | 20 | |
Repeati | 101 – 120 | 31 PublicationAdd BLAST | 20 | |
Repeati | 121 – 140 | 41 PublicationAdd BLAST | 20 | |
Repeati | 141 – 160 | 51 PublicationAdd BLAST | 20 | |
Repeati | 161 – 180 | 61 PublicationAdd BLAST | 20 | |
Repeati | 181 – 200 | 71 PublicationAdd BLAST | 20 | |
Repeati | 201 – 220 | 81 PublicationAdd BLAST | 20 | |
Repeati | 221 – 240 | 91 PublicationAdd BLAST | 20 | |
Repeati | 241 – 260 | 101 PublicationAdd BLAST | 20 | |
Repeati | 261 – 280 | 111 PublicationAdd BLAST | 20 | |
Repeati | 281 – 300 | 121 PublicationAdd BLAST | 20 | |
Repeati | 301 – 320 | 131 PublicationAdd BLAST | 20 | |
Repeati | 321 – 340 | 141 PublicationAdd BLAST | 20 | |
Repeati | 341 – 360 | 151 PublicationAdd BLAST | 20 | |
Repeati | 361 – 380 | 161 PublicationAdd BLAST | 20 | |
Repeati | 381 – 400 | 171 PublicationAdd BLAST | 20 | |
Repeati | 401 – 420 | 181 PublicationAdd BLAST | 20 | |
Repeati | 421 – 440 | 191 PublicationAdd BLAST | 20 | |
Repeati | 441 – 460 | 201 PublicationAdd BLAST | 20 | |
Repeati | 461 – 480 | 211 PublicationAdd BLAST | 20 | |
Repeati | 481 – 500 | 221 PublicationAdd BLAST | 20 | |
Repeati | 501 – 520 | 231 PublicationAdd BLAST | 20 | |
Repeati | 521 – 540 | 241 PublicationAdd BLAST | 20 | |
Repeati | 541 – 560 | 251 PublicationAdd BLAST | 20 | |
Repeati | 561 – 580 | 261 PublicationAdd BLAST | 20 | |
Repeati | 581 – 600 | 271 PublicationAdd BLAST | 20 | |
Repeati | 601 – 620 | 281 PublicationAdd BLAST | 20 | |
Repeati | 621 – 640 | 291 PublicationAdd BLAST | 20 | |
Repeati | 641 – 660 | 301 PublicationAdd BLAST | 20 | |
Repeati | 661 – 680 | 311 PublicationAdd BLAST | 20 | |
Repeati | 681 – 700 | 321 PublicationAdd BLAST | 20 | |
Repeati | 701 – 720 | 331 PublicationAdd BLAST | 20 | |
Repeati | 721 – 740 | 341 PublicationAdd BLAST | 20 | |
Repeati | 741 – 760 | 351 PublicationAdd BLAST | 20 | |
Repeati | 761 – 780 | 361 PublicationAdd BLAST | 20 | |
Repeati | 781 – 800 | 371 PublicationAdd BLAST | 20 | |
Repeati | 801 – 820 | 381 PublicationAdd BLAST | 20 | |
Repeati | 821 – 840 | 391 PublicationAdd BLAST | 20 | |
Repeati | 841 – 860 | 401 PublicationAdd BLAST | 20 | |
Repeati | 861 – 880 | 411 PublicationAdd BLAST | 20 | |
Repeati | 881 – 900 | 421 PublicationAdd BLAST | 20 | |
Repeati | 901 – 920 | 431 PublicationAdd BLAST | 20 | |
Repeati | 921 – 940 | 441 PublicationAdd BLAST | 20 | |
Repeati | 941 – 960 | 451 PublicationAdd BLAST | 20 | |
Repeati | 961 – 980 | 46; approximate1 PublicationAdd BLAST | 20 | |
Repeati | 981 – 1000 | 47; approximate1 PublicationAdd BLAST | 20 | |
Repeati | 1001 – 1020 | 48; approximate1 PublicationAdd BLAST | 20 | |
Domaini | 1039 – 1148 | SEAPROSITE-ProRule annotationAdd BLAST | 110 |
Region
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Regioni | 126 – 965 | 42 X 20 AA approximate tandem repeats of P-A-P-G-S-T-A-P-P-A-H-G-V-T-S-A-P-D-T-RAdd BLAST | 840 | |
Regioni | 1192 – 1228 | Interaction with P53Add BLAST | 37 | |
Regioni | 1223 – 1230 | Required for interaction with GSK3B | 8 | |
Regioni | 1233 – 1241 | Required for interaction with beta- and gamma-catenins | 9 |
Motif
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Motifi | 1203 – 1206 | Interaction with GRB2 | 4 | |
Motifi | 1229 – 1232 | Interaction with SRC and ESR1 | 4 | |
Motifi | 1243 – 1246 | Required for interaction with AP1S2 | 4 |
Keywords - Domaini
Repeat, Signal, Transmembrane, Transmembrane helixPhylogenomic databases
eggNOGi | ENOG502QWCT, Eukaryota |
GeneTreei | ENSGT00710000106874 |
HOGENOMi | CLU_1386987_0_0_1 |
InParanoidi | P15941 |
OrthoDBi | 945460at2759 |
PhylomeDBi | P15941 |
Family and domain databases
DisProti | DP01790 |
Gene3Di | 3.30.70.960, 1 hit |
IDEALi | IID00195 |
InterProi | View protein in InterPro IPR023217, Mucin-1 IPR000082, SEA_dom IPR036364, SEA_dom_sf |
PANTHERi | PTHR10006, PTHR10006, 7 hits |
Pfami | View protein in Pfam PF01390, SEA, 1 hit |
SMARTi | View protein in SMART SM00200, SEA, 1 hit |
SUPFAMi | SSF82671, SSF82671, 1 hit |
PROSITEi | View protein in PROSITE PS50024, SEA, 1 hit |
s (17+)i Sequence
Sequence statusi: Complete.
: The displayed sequence is further processed into a mature form. Sequence processingi
This entry describes 17 produced by isoformsialternative splicing. AlignAdd to basketThis entry has 17 described isoforms and 17 potential isoforms that are computationally mapped.Show allAlign All
This isoform has been chosen as the sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. canonicali
10 20 30 40 50
MTPGTQSPFF LLLLLTVLTV VTGSGHASST PGGEKETSAT QRSSVPSSTE
60 70 80 90 100
KNAVSMTSSV LSSHSPGSGS STTQGQDVTL APATEPASGS AATWGQDVTS
110 120 130 140 150
VPVTRPALGS TTPPAHDVTS APDNKPAPGS TAPPAHGVTS APDTRPAPGS
160 170 180 190 200
TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
210 220 230 240 250
APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS
260 270 280 290 300
TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
310 320 330 340 350
APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS
360 370 380 390 400
TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
410 420 430 440 450
APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS
460 470 480 490 500
TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
510 520 530 540 550
APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS
560 570 580 590 600
TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
610 620 630 640 650
APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS
660 670 680 690 700
TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
710 720 730 740 750
APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS
760 770 780 790 800
TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
810 820 830 840 850
APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS
860 870 880 890 900
TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
910 920 930 940 950
APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDNRPALGS
960 970 980 990 1000
TAPPVHNVTS ASGSASGSAS TLVHNGTSAR ATTTPASKST PFSIPSHHSD
1010 1020 1030 1040 1050
TPTTLASHST KTDASSTHHS SVPPLTSSNH STSPQLSTGV SFFFLSFHIS
1060 1070 1080 1090 1100
NLQFNSSLED PSTDYYQELQ RDISEMFLQI YKQGGFLGLS NIKFRPGSVV
1110 1120 1130 1140 1150
VQLTLAFREG TINVHDVETQ FNQYKTEAAS RYNLTISDVS VSDVPFPFSA
1160 1170 1180 1190 1200
QSGAGVPGWG IALLVLVCVL VALAIVYLIA LAVCQCRRKN YGQLDIFPAR
1210 1220 1230 1240 1250
DTYHPMSEYP TYHTHGRYVP PSSTDRSPYE KVSAGNGGSS LSYTNPAVAA
TSANL
The sequence of this isoform differs from the canonical sequence as follows:
19-19: T → TATTAPKPAT
54-1053: Missing.
The sequence of this isoform differs from the canonical sequence as follows:
19-19: T → TATTAPKPAT
54-1053: Missing.
1077-1181: Missing.
The sequence of this isoform differs from the canonical sequence as follows:
54-1035: Missing.
1141-1180: VSDVPFPFSA...VALAIVYLIA → GCLSVPPKEL...LPHPWALCAP
1181-1255: Missing.
The sequence of this isoform differs from the canonical sequence as follows:
54-96: VSMTSSVLSS...ASGSAATWGQ → IPAPTTTKSC...SSGQDLWWYN
97-1255: Missing.
The sequence of this isoform differs from the canonical sequence as follows:
19-19: T → TATTAPKPAT
54-1093: Missing.
The sequence of this isoform differs from the canonical sequence as follows:
19-19: T → TATTAPKPAT
54-1151: Missing.
The sequence of this isoform differs from the canonical sequence as follows:
19-19: T → TATTAPKPAT
54-1053: Missing.
1232-1255: VSAGNGGSSLSYTNPAVAATSANL → RQNGWSTMPRGALPEESQG
Computationally mapped potential isoform sequencesi
There are 17 potential isoforms mapped to this entry.BLASTAlignShow allAdd to basketA0A087X2A4 | A0A087X2A4_HUMAN | MUC1-CT | MUC1 | 484 | Annotation score: | ||
A0A0C4DGW3 | A0A0C4DGW3_HUMAN | MUC1-CT | MUC1 | 475 | Annotation score: | ||
A0A0A0MRB3 | A0A0A0MRB3_HUMAN | MUC1-CT | MUC1 | 241 | Annotation score: | ||
A0A087WWM1 | A0A087WWM1_HUMAN | MUC1-CT | MUC1 | 1,262 | Annotation score: | ||
B1AVQ7 | B1AVQ7_HUMAN | MUC1-CT | MUC1 | 229 | Annotation score: | ||
A0A0A0MSH4 | A0A0A0MSH4_HUMAN | MUC1-CT | MUC1 | 268 | Annotation score: | ||
A0A087WVJ0 | A0A087WVJ0_HUMAN | MUC1-CT | MUC1 | 228 | Annotation score: | ||
A0A087WZZ6 | A0A087WZZ6_HUMAN | MUC1-CT | MUC1 | 123 | Annotation score: | ||
A0A087X061 | A0A087X061_HUMAN | MUC1-CT | MUC1 | 96 | Annotation score: | ||
A6ZIE4 | A6ZIE4_HUMAN | MUC1 isoform M10 | MUC1 | 189 | Annotation score: | ||
There are more potential isoformsShow all |
Sequence cautioni
Experimental Info
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Sequence conflicti | 2 | T → A in AAD14369 (PubMed:8604237).Curated | 1 | |
Sequence conflicti | 134 | P → Q in AAA35757 (PubMed:2597151).Curated | 1 | |
Sequence conflicti | 154 | P → Q in AAA35757 (PubMed:2597151).Curated | 1 | |
Sequence conflicti | 1021 | S → T in AAA35805 (PubMed:2318825).Curated | 1 | |
Sequence conflicti | 1021 | S → T in AAA35807 (PubMed:2318825).Curated | 1 | |
Sequence conflicti | 1021 | S → T in AAA59876 (PubMed:1697589).Curated | 1 | |
Sequence conflicti | 1143 | D → G in AAP97018 (PubMed:22941036).Curated | 1 | |
Sequence conflicti | 1193 | Q → L in AAK30142 (PubMed:15969018).Curated | 1 | |
Sequence conflicti | 1231 | K → T in AAD10858 (PubMed:9212228).Curated | 1 | |
Sequence conflicti | 1251 | T → A in AAA60019 (PubMed:2394722).Curated | 1 |
Polymorphismi
Natural variant
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Natural variantiVAR_019390 | 1117 | V → M3 PublicationsCorresponds to variant dbSNP:rs1611770Ensembl. | 1 | |
Natural variantiVAR_019391 | 1142 | S → N1 PublicationCorresponds to variant dbSNP:rs11465207Ensembl. | 1 |
Alternative sequence
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Alternative sequenceiVSP_003281 | 19 – 21 | Missing in isoform 3. 1 Publication | 3 | |
Alternative sequenceiVSP_003280 | 19 | T → TATTAPKPAT in isoform 2, isoform Y-LSP, isoform E2, isoform J13, isoform S2 and isoform T10. 6 Publications | 1 | |
Alternative sequenceiVSP_003282 | 20 – 31 | Missing in isoform 4. 1 PublicationAdd BLAST | 12 | |
Alternative sequenceiVSP_047872 | 54 – 1151 | Missing in isoform E2. 1 PublicationAdd BLAST | 1098 | |
Alternative sequenceiVSP_047873 | 54 – 1093 | Missing in isoform T10. 1 PublicationAdd BLAST | 1040 | |
Alternative sequenceiVSP_003285 | 54 – 1053 | Missing in isoform J13, isoform Y, isoform Y-LSP and isoform S2. 6 PublicationsAdd BLAST | 1000 | |
Alternative sequenceiVSP_003286 | 54 – 1035 | Missing in isoform 8, isoform 9 and isoform M6. 4 PublicationsAdd BLAST | 982 | |
Alternative sequenceiVSP_047575 | 54 – 96 | VSMTS…ATWGQ → IPAPTTTKSCRETFLKCFCR FINKGVFWASPILSSGQDLW WYN in isoform ZD. 2 PublicationsAdd BLAST | 43 | |
Alternative sequenceiVSP_035046 | 54 – 87 | VSMTS…ATEPA → IPAPTTTKSCRETFLKCFCR FINKGVFWASPILS in isoform F. 1 PublicationAdd BLAST | 34 | |
Alternative sequenceiVSP_003283 | 54 – 70 | VSMTS…PGSGS → IPAPTTTKSCRETFLKW in isoform 6. 2 PublicationsAdd BLAST | 17 | |
Alternative sequenceiVSP_003284 | 71 – 1095 | Missing in isoform 6. 2 PublicationsAdd BLAST | 1025 | |
Alternative sequenceiVSP_035047 | 88 – 1139 | Missing in isoform F. 1 PublicationAdd BLAST | 1052 | |
Alternative sequenceiVSP_047576 | 97 – 1255 | Missing in isoform ZD. 2 PublicationsAdd BLAST | 1159 | |
Alternative sequenceiVSP_003287 | 1077 – 1181 | Missing in isoform 9 and isoform S2. 3 PublicationsAdd BLAST | 105 | |
Alternative sequenceiVSP_003288 | 1077 – 1087 | FLQIYKQGGFL → VSIGLSFPMLP in isoform 5. 1 PublicationAdd BLAST | 11 | |
Alternative sequenceiVSP_003289 | 1088 – 1255 | Missing in isoform 5. 1 PublicationAdd BLAST | 168 | |
Alternative sequenceiVSP_046962 | 1141 – 1180 | VSDVP…VYLIA → GCLSVPPKELRAAGHLSSPG YLPSYERVPHLPHPWALCAP in isoform M6. 2 PublicationsAdd BLAST | 40 | |
Alternative sequenceiVSP_046963 | 1181 – 1255 | Missing in isoform M6. 2 PublicationsAdd BLAST | 75 | |
Alternative sequenceiVSP_047874 | 1232 – 1255 | VSAGN…TSANL → RQNGWSTMPRGALPEESQG in isoform J13. 1 PublicationAdd BLAST | 24 |
Sequence databases
Genome annotation databases
Keywords - Coding sequence diversityi
Alternative splicing, PolymorphismSimilar proteinsi
Cross-referencesi
Web resourcesi
Mucin database |
NIEHS-SNPs |
Sequence databases
3D structure databases
Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
1SM3 | X-ray | 1.95 | P | 919-931 | [»] | |
2ACM | NMR | - | A | 1042-1097 | [»] | |
B | 1098-1152 | [»] | ||||
2FO4 | X-ray | 2.70 | P | 140-146 | [»] | |
5T6P | X-ray | 1.97 | E/F | 921-928 | [»] | |
5T78 | X-ray | 2.20 | E/F | 921-928 | [»] | |
6FZQ | X-ray | 1.70 | P | 921-926 | [»] | |
6FZR | X-ray | 1.80 | P | 921-926 | [»] | |
6TGG | X-ray | 2.00 | P | 921-926 | [»] | |
SMRi | P15941 | |||||
ModBasei | Search... | |||||
PDBe-KBi | Search... |
Protein-protein interaction databases
BioGRIDi | 110669, 147 interactors |
DIPi | DIP-41890N |
IntActi | P15941, 121 interactors |
MINTi | P15941 |
STRINGi | 9606.ENSP00000484824 |
Chemistry databases
ChEMBLi | CHEMBL3580494 |
DrugBanki | DB11090, Potassium nitrate DB06584, TG4010 |
Protein family/group databases
MEROPSi | S71.001 |
PTM databases
GlyConnecti | 372, 9 O-Linked glycans 373, 8 O-Linked glycans 374, 8 O-Linked glycans 375, 10 O-Linked glycans 376, 10 O-Linked glycans 377, 7 O-Linked glycans 413, 5 N-Linked glycans (1 site), 14 O-Linked glycans |
GlyGeni | P15941, 13 sites, 5 O-linked glycans (4 sites) |
iPTMneti | P15941 |
PhosphoSitePlusi | P15941 |
SwissPalmi | P15941 |
UniCarbKBi | P15941 |
Polymorphism and mutation databases
BioMutai | MUC1 |
DMDMi | 296439295 |
Proteomic databases
CPTACi | CPTAC-146 CPTAC-147 CPTAC-719 CPTAC-730 |
jPOSTi | P15941 |
MassIVEi | P15941 |
MaxQBi | P15941 |
PaxDbi | P15941 |
PeptideAtlasi | P15941 |
PRIDEi | P15941 |
ProteomicsDBi | 1779 53249 [P15941-1] 53250 [P15941-10] 53251 [P15941-2] 53252 [P15941-3] 53253 [P15941-4] 53254 [P15941-5] 53255 [P15941-6] 53256 [P15941-7] 53257 [P15941-8] 53258 [P15941-9] 58806 6245 69255 69256 767 |
Protocols and materials databases
ABCDi | P15941, 33 sequenced antibodies |
Antibodypediai | 1298, 4452 antibodies |
CPTCi | P15941, 2 antibodies |
DNASUi | 4582 |
Genome annotation databases
Organism-specific databases
CTDi | 4582 |
DisGeNETi | 4582 |
EuPathDBi | HostDB:ENSG00000185499.16 |
GeneCardsi | MUC1 |
GeneReviewsi | MUC1 |
HGNCi | HGNC:7508, MUC1 |
HPAi | ENSG00000185499, Tissue enhanced (gallbladder, kidney, lung) |
MalaCardsi | MUC1 |
MIMi | 113720, gene 158340, gene 174000, phenotype |
neXtProti | NX_P15941 |
OpenTargetsi | ENSG00000185499 |
Orphaneti | 88949, MUC1-related autosomal dominant tubulointerstitial kidney disease |
PharmGKBi | PA31309 |
GenAtlasi | Search... |
Phylogenomic databases
eggNOGi | ENOG502QWCT, Eukaryota |
GeneTreei | ENSGT00710000106874 |
HOGENOMi | CLU_1386987_0_0_1 |
InParanoidi | P15941 |
OrthoDBi | 945460at2759 |
PhylomeDBi | P15941 |
Enzyme and pathway databases
PathwayCommonsi | P15941 |
Reactomei | R-HSA-5083625, Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) R-HSA-5083632, Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) R-HSA-5083636, Defective GALNT12 causes colorectal cancer 1 (CRCS1) R-HSA-5621480, Dectin-2 family R-HSA-6785807, Interleukin-4 and Interleukin-13 signaling R-HSA-913709, O-linked glycosylation of mucins R-HSA-977068, Termination of O-glycan biosynthesis |
SIGNORi | P15941 |
Miscellaneous databases
BioGRID-ORCSi | 4582, 5 hits in 848 CRISPR screens |
ChiTaRSi | MUC1, human |
EvolutionaryTracei | P15941 |
GeneWikii | MUC1 |
GenomeRNAii | 4582 |
Pharosi | P15941, Tbio |
PROi | PR:P15941 |
RNActi | P15941, protein |
SOURCEi | Search... |
Gene expression databases
Bgeei | ENSG00000185499, Expressed in body of stomach and 212 other tissues |
ExpressionAtlasi | P15941, baseline and differential |
Genevisiblei | P15941, HS |
Family and domain databases
DisProti | DP01790 |
Gene3Di | 3.30.70.960, 1 hit |
IDEALi | IID00195 |
InterProi | View protein in InterPro IPR023217, Mucin-1 IPR000082, SEA_dom IPR036364, SEA_dom_sf |
PANTHERi | PTHR10006, PTHR10006, 7 hits |
Pfami | View protein in Pfam PF01390, SEA, 1 hit |
SMARTi | View protein in SMART SM00200, SEA, 1 hit |
SUPFAMi | SSF82671, SSF82671, 1 hit |
PROSITEi | View protein in PROSITE PS50024, SEA, 1 hit |
ProtoNeti | Search... |
MobiDBi | Search... |
Entry informationi
Entry namei | MUC1_HUMAN | |
Accessioni | P15941Primary (citable) accession number: P15941 Secondary accession number(s): A5YRV1 Q9Y4J2 | |
Entry historyi | Integrated into UniProtKB/Swiss-Prot: | April 1, 1990 |
Last sequence update: | May 18, 2010 | |
Last modified: | December 2, 2020 | |
This is version 225 of the entry and version 3 of the sequence. See complete history. | ||
Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
Annotation program | Chordata Protein Annotation Program | |
Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. |
Miscellaneousi
Keywords - Technical termi
3D-structure, Direct protein sequencing, Reference proteomeDocuments
- Human polymorphisms and disease mutations
Index of human polymorphisms and disease mutations - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - Human chromosome 1
Human chromosome 1: entries, gene names and cross-references to MIM - Human entries with polymorphisms or disease mutations
List of human entries with polymorphisms or disease mutations - Human cell differentiation molecules
CD nomenclature of surface proteins of human leucocytes and list of entries